Clinical Trial

Survey on Epidemiology of Hypoparathyroidism in France

Study acronym: Epi-Hypo
Recruiting
View on ClinicalTrials.gov →
Summary
Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2016-07-17; most recent amendment 2024-09-22.
Trial Details
NCT Number NCT02838927
Lead Sponsor European Georges Pompidou Hospital
Collaborators: Oscar - Filière Santé Maladies Rares
Conditions Hypoparathyroidism
Enrollment 3,000 participants
Start Date 2016-07
Primary Completion 2030-09 (estimated)
Study Completion 2031-09 (estimated)
Updated on ClinicalTrials.gov 2024-09-24